Seco (IOT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jun, 2026Executive summary
Net sales for the first nine months of 2024 were €139.4M, down 14% year-over-year, mainly due to customer destocking and lower sales volumes across geographies and sectors.
Clea software business grew 4% year-over-year to €17.0M, now representing 12% of net sales, with a 214 bps increase in contribution.
Gross margin improved to 52.1% of revenue (+261 bps YoY), supported by a better sales mix and reduced component costs.
Adjusted EBITDA was €20.4M (14.7% of sales), down 45% year-over-year, with net income dropping 90% to €1.6M and reported net income at -€7.6M due to non-recurring items.
Strategic partnerships with NXP, Raspberry Pi, and Qualcomm were announced, expanding Clea and edge AI offerings and supporting future growth.
Financial highlights
Net sales declined to €139.4M from €162.1M in 9M23, mainly due to customer destocking and low demand.
Clea software revenue increased by 4% year-over-year to €17.0M, now 12% of total sales.
Gross margin rose to 52.1% (up 261 bps), but gross profit fell due to lower volumes.
Adjusted EBITDA margin was 14.7% for the nine months, totaling €20.4M.
Adjusted net financial debt increased to €56.9M as of September 30, 2024.
Outlook and guidance
Full-year 2024 guidance confirmed: revenues expected to exceed €180M and gross margin above 50%.
Revenue growth expected to return to positive in H1 2025 as business fundamentals stabilize.
Organic growth of 15% anticipated in 2025 under normalized market conditions.
Cost reductions in OPEX are expected to benefit profitability in Q4 and throughout 2025.
Visibility for 2025 is improving, with order intake and book-to-bill ratios turning positive.
Latest events from Seco
- Sales fell 14.8% but gross margin rose to 52.7% as Clea software grew 17%.IOT
Q2 202417 Jun 2026 - Sales fell 12.5% to €183.5M, but margins held firm and 2025 recovery is expected.IOT
Q4 202417 Jun 2026 - Q1 2025 sales flat YoY, margins strong, Clea recurring revenue up, and order pipeline robust.IOT
Q1 202517 Jun 2026 - Net sales up 2.91% to €48.5m, Clea recurring revenue up 20%, and strong Q2 outlook.IOT
Q1 202613 May 2026 - FY25 net sales up 8% YoY, margins and cash flow improved, record backlog for 2026.IOT
Q4 202523 Mar 2026 - Sales up 5%, margin at 53.8%, EBITDA up 50.8%, and €200M+ FY25 guidance confirmed.IOT
Q3 202512 Nov 2025 - H1 2025 delivered higher sales, margins, and profit, with FY25 revenue set to exceed €200M.IOT
Q2 202512 Sep 2025